A Brampton family is seeking community support to raise millions of dollars for an experimental gene therapy treatment in the United States for their two-year-old child, Zoravar/Zorawar Singh, who has a rare genetic disorder known as AADC deficiency (aromatic L-amino acid decarboxylase deficiency). The family says the treatment is not approved in Canada.
According to reporting, the family’s effort follows the province’s decision not to fund the out-of-country treatment. Coverage focuses on the urgency of the fundraising campaign and the child’s diagnosis, with donors being asked to help cover the costs of getting the therapy abroad.
The Toronto Sun leads with the specific fundraising goal amount and frames the story around the family’s hopes to raise $5.5 million. City News Toronto emphasizes the broader community call for support and the role of the province’s funding denial in prompting the campaign. Both accounts center on the child’s rare condition and the cross-border nature of the medical treatment.